JPH01156968A - イミダゾジアゼピン誘導体 - Google Patents

イミダゾジアゼピン誘導体

Info

Publication number
JPH01156968A
JPH01156968A JP63267347A JP26734788A JPH01156968A JP H01156968 A JPH01156968 A JP H01156968A JP 63267347 A JP63267347 A JP 63267347A JP 26734788 A JP26734788 A JP 26734788A JP H01156968 A JPH01156968 A JP H01156968A
Authority
JP
Japan
Prior art keywords
formula
tables
formulas
methyl
chemical formulas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP63267347A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0369913B2 (en:Method
Inventor
Willy Haefely
ウイリー・ヘーフエリイ
Walter Hunkeler
ヴアルター・フンケラー
Emilio Kyburz
エミリオ・キブルツ
Moehller Hans
ハンス・メーラー
Lorenzo Pieri
ロレンツオ・ピエリイ
Petar Polc
ペーター・ポルク
Max Gerecke
マツクス・ゲーレケ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27509256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPH01156968(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH01156968A publication Critical patent/JPH01156968A/ja
Publication of JPH0369913B2 publication Critical patent/JPH0369913B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
JP63267347A 1979-10-04 1988-10-25 イミダゾジアゼピン誘導体 Granted JPH01156968A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
CH8971/79-0 1979-10-04
CH897179 1979-10-04
CH8972/79-2 1979-10-04
CH897279 1979-10-04
CH1066479 1979-11-30
CH10665/79-3 1979-11-30
CH10664/79-1 1979-11-30
CH1066579 1979-11-30
CH5716/80-7 1980-07-25
CH571680 1980-07-25

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP13684480A Division JPS5659776A (en) 1979-10-04 1980-10-02 Imidazodiazepine derivative

Publications (2)

Publication Number Publication Date
JPH01156968A true JPH01156968A (ja) 1989-06-20
JPH0369913B2 JPH0369913B2 (en:Method) 1991-11-05

Family

ID=27509256

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63267347A Granted JPH01156968A (ja) 1979-10-04 1988-10-25 イミダゾジアゼピン誘導体

Country Status (23)

Country Link
US (10) US4316839A (en:Method)
EP (1) EP0027214B1 (en:Method)
JP (1) JPH01156968A (en:Method)
AR (1) AR227293A1 (en:Method)
AU (1) AU533641B2 (en:Method)
BR (1) BR8006404A (en:Method)
CA (1) CA1143728A (en:Method)
DE (1) DE3067868D1 (en:Method)
DK (1) DK168094B1 (en:Method)
FI (1) FI73683C (en:Method)
GB (1) GB2060632B (en:Method)
GR (1) GR70772B (en:Method)
HU (1) HU182675B (en:Method)
IE (1) IE50318B1 (en:Method)
IL (1) IL61160A (en:Method)
LU (1) LU88298I2 (en:Method)
MC (1) MC1355A1 (en:Method)
NL (1) NL930056I2 (en:Method)
NO (1) NO155774C (en:Method)
NZ (1) NZ195071A (en:Method)
PH (1) PH16607A (en:Method)
PT (1) PT71874B (en:Method)
ZW (1) ZW21580A1 (en:Method)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1184175A (en) * 1981-02-27 1985-03-19 Walter Hunkeler Imidazodiazepines
CA1185602A (en) * 1981-02-27 1985-04-16 Emilio Kyburz Imidazodiazepines
US4352817A (en) * 1981-02-27 1982-10-05 Hoffmann-La Roche Inc. Imidazo-diazepines and their use
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
CA1173441A (en) * 1981-02-27 1984-08-28 Hoffmann-La Roche Limited Imidazodiazepines
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
US4723003A (en) * 1983-05-18 1988-02-02 Hoechst-Roussel Pharmaceuticals Inc. Benzopyrrolobenzodiazepines and quinobenzodiazepines
DE3587913D1 (de) * 1984-01-19 1994-10-06 Hoffmann La Roche Imidazodiazepin-Derivate.
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
US4745112A (en) * 1985-05-17 1988-05-17 A/S Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method III
US4622321A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
FI880814A7 (fi) * 1987-03-10 1988-09-11 Hoffmann La Roche Imidazodiazepin-derivat.
GB8720414D0 (en) * 1987-08-28 1987-10-07 Roussel Lab Ltd Chemical compounds
NZ230193A (en) * 1988-08-05 1992-01-29 Hoffmann La Roche A radioiodinated benzodiazepine derivative and brain imaging composition
US5096695A (en) * 1988-08-05 1992-03-17 Hoffmann-Laroche Inc. Radioiodine benzodiazepines as brain imaging agents
CA1327572C (en) * 1988-08-31 1994-03-08 F. Hoffmann-La Roche Ag Imidazodiazepine derivatives
GB8909700D0 (en) * 1989-04-27 1989-06-14 Roussel Lab Ltd Chemical compounds
CA2015336A1 (en) * 1989-05-19 1990-11-19 F. Hoffmann-La Roche Ag Imidazodiazepines for the treatment of neurological symptoms
FR2660310B1 (fr) * 1990-03-27 1992-06-05 Adir Nouveaux derives de la 4h-pyrrolo[1,2a] thieno[2,3-f] diazepine[1,4], leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5371080A (en) * 1990-06-22 1994-12-06 Novo Nordisk A/S Imidazoquinazoline compounds and their use
US5276028A (en) * 1990-06-22 1994-01-04 Nordisk A/S Imidazoquinoxaline compounds
TW201311B (en:Method) * 1991-06-17 1993-03-01 Hoffmann La Roche
US5674865A (en) * 1991-10-18 1997-10-07 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5438035A (en) * 1994-06-24 1995-08-01 American Cyanamid Company Methods for controlling undesirable plant species with benzodiazepine compounds
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5670640A (en) 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
GB2328940B (en) * 1997-09-05 1999-12-08 Dong Kook Pharm Co Ltd A process for preparing benzodiazepine derivatives
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
AU2005293820B2 (en) 2004-10-12 2010-11-25 F. Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
WO2006045430A1 (en) 2004-10-20 2006-05-04 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
JP4751398B2 (ja) 2004-10-20 2011-08-17 エフ．ホフマン−ラ ロシュ アーゲー ハロゲン置換ベンゾジアゼピン誘導体
WO2006063708A1 (en) 2004-12-14 2006-06-22 F.Hoffmann-La Roche Ag Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
EP1888594A2 (en) * 2005-05-16 2008-02-20 Wisys Technology Foundation, Inc. Gabaergic agents to treat memory deficits
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
KR20090064418A (ko) * 2006-09-08 2009-06-18 브레인셀즈 인코퍼레이션 4-아실아미노피리딘 유도체 포함 조합물
US20080103165A1 (en) * 2006-09-19 2008-05-01 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
BRPI0815579A2 (pt) 2007-08-20 2015-02-18 Evotec Neurosciences Gmbh Tratamento de distúrbio do sono
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
GB0917612D0 (en) * 2009-10-08 2009-11-25 Ge Healthcare Ltd In vivo imaging agents
CN103502224A (zh) 2011-02-23 2014-01-08 克鲁莱斯有限公司 氟马西尼络合物、包含该络合物的组合物及其用途
CN102267999B (zh) * 2011-07-15 2013-05-29 海南美兰史克制药有限公司 一种氟马西尼化合物及其制法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659776A (en) * 1979-10-04 1981-05-23 Hoffmann La Roche Imidazodiazepine derivative
JPS6411028A (en) * 1987-07-02 1989-01-13 Amada Co Ltd Turret punch press

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933794A (en) * 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4031079A (en) * 1975-09-22 1977-06-21 Mcneil Laboratories, Incorporated Intermediates for 2-aminobenzodiazepine-5-ones
US4002610A (en) * 1975-09-22 1977-01-11 Mcneil Laboratories, Incorporated 2-Aminobenzodiazepine-5-ones
US4118386A (en) * 1977-04-04 1978-10-03 Hoffmann-La Roche Inc. Synthesis of imidazo[1,5-a]diazepine-3-carboxylates
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5659776A (en) * 1979-10-04 1981-05-23 Hoffmann La Roche Imidazodiazepine derivative
JPS6411028A (en) * 1987-07-02 1989-01-13 Amada Co Ltd Turret punch press

Also Published As

Publication number Publication date
EP0027214B1 (de) 1984-05-16
LU88298I2 (fr) 1994-05-04
US4316839A (en) 1982-02-23
CA1143728A (en) 1983-03-29
US4346034A (en) 1982-08-24
US4346031A (en) 1982-08-24
US4346030A (en) 1982-08-24
US4346033A (en) 1982-08-24
US4359420A (en) 1982-11-16
NO802946L (no) 1981-04-06
JPH0369913B2 (en:Method) 1991-11-05
GR70772B (en:Method) 1983-03-22
IL61160A0 (en) 1980-11-30
FI803135L (fi) 1981-04-05
FI73683B (fi) 1987-07-31
ZW21580A1 (en) 1981-04-29
AU533641B2 (en) 1983-12-01
BR8006404A (pt) 1981-04-14
AU6278280A (en) 1981-04-09
PH16607A (en) 1983-11-24
NL930056I1 (nl) 1993-09-01
IE802056L (en) 1981-04-04
AR227293A1 (es) 1982-10-15
US4346035A (en) 1982-08-24
FI73683C (fi) 1987-11-09
NO155774C (no) 1987-05-27
DK391280A (da) 1981-04-05
NO155774B (no) 1987-02-16
NZ195071A (en) 1984-08-24
PT71874B (en) 1982-03-31
GB2060632A (en) 1981-05-07
MC1355A1 (fr) 1981-08-10
US4346036A (en) 1982-08-24
IL61160A (en) 1983-07-31
US4363762A (en) 1982-12-14
NL930056I2 (nl) 1993-11-16
DE3067868D1 (en) 1984-06-20
DK168094B1 (da) 1994-02-07
PT71874A (en) 1980-11-01
EP0027214A1 (de) 1981-04-22
IE50318B1 (en) 1986-04-02
US4346032A (en) 1982-08-24
HU182675B (en) 1984-02-28
GB2060632B (en) 1983-11-02

Similar Documents

Publication Publication Date Title
JPH01156968A (ja) イミダゾジアゼピン誘導体
US4352815A (en) Imidazo-benzodiazepines and their use
JP3782475B2 (ja) 三環式ジアゼピンバソプレシン拮抗薬およびオキシトシン拮抗薬
JP3001979B2 (ja) ヒドロキシメチル−イミダゾジアゼピン類及びそれらのエステル
JPS6333382A (ja) 新規ヘトラゼピンおよびその製法
EA000056B1 (ru) Трициклические диазепины в качестве антагонистов вазопрессина, способ их получения и способ лечения с использованием трициклических диазепинов
US3933794A (en) 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
HU185089B (en) Process for producing imidazo-diazepine derivatives
JPH10512572A (ja) バソプレッシン・アンタゴニストとしての二環式ベンズアゼピン誘導体
JPS5933286A (ja) イミダゾベンゾジアゼピン類
AU769666B2 (en) Imidazodiazepine derivative
HU182213B (en) Process for preparing new pyrazolo-benzodiazepine compounds
JPS6411028B2 (en:Method)
US3927016A (en) 6-Substituted 4H-imidazo (1,2-a) (1,4)-benzodiazepine-1-carboxaldehydes and processes for their production
CA2137668C (en) Benzodiazepines and compositions for treating anxiety and panic disorders, and idiopathic and psychomotor epilepsy
US3917627A (en) 6-Substituted 4H-imidazo{8 1,2-a{9 {8 1,4{9 benzodiazepines and process for their production
US3856802A (en) 1,6-DISUBSTITUTED-4H-5-{8 4,3-a{9 BENZODIAZEPINES
JPH10505098A (ja) オキサゾリル−及びチアゾリルイミダゾ−ベンゾ−及びチエノジアゼピン類、並びに医薬品としてのそれらの用途
KR840000993B1 (ko) 이미다조디아제핀 유도체의 제조방법
US3996230A (en) 1-Piperazino-6-(2-pyridyl)-4H-s-triazolo[4,3-a][1,4]benzodiazepines
HU202531B (en) Process for producing imidazodiazepine derivatives and pharmaceutical compositions comprising such compounds
US3862956A (en) 2,4-Dihydro-2-substituted-1H-s-triazola{8 4,3-a{9 {8 1,4{9 -benzodiazepines